BD To Spin Off Diabetes Care Business - Quick Facts

Becton, Dickinson and Company (BDX) said its board has unanimously authorized management to proceed with a plan to spin off the Diabetes Care business as an independent, publicly traded company. BD expects the spinoff to be accomplished through a distribution of stock in new company to BD shareholders. Devdatt Kurdikar, currently worldwide president of BD Diabetes Care, will be chief executive officer of the new company.

The Diabetes Care business is the leading producer of diabetes injection devices, producing approximately 8 billion injection devices annually and serving about 30 million patients.

Following the spinoff, BD will maintain category leadership positions across its portfolio in the BD Medical, BD Life Sciences and BD Interventional segments.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Viona Pharmaceuticals Inc. has recalled type 2 diabetes drug Metformin in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Ford Motor Co. on Monday issued a recall for a total of 19,626 2021 F-Series Super Duty vehicles with dual rear wheels in North America. These include 17,616 vehicles in the U.S. and federal territories; 1,779 in Canada; and 231 in Mexico. The affected vehicles are equipped with front-wheel hub extenders... Royal Philips has recalled specific sleep and respiratory care devices due to the potential health risks related to the polyester-based polyurethane or PE-PUR sound abatement foam component. The affected products include Bi-Level Positive Airway Pressure or Bi-Level PAP, Continuous Positive Airway Pressure or CPAP, and mechanical ventilator devices.
Follow RTT